INTRODUCTION
Hepatitis C virus (HCV) often causes a prolonged and persistent infection, and an association between hepatocellular carcinoma and HCV infection has been noted (Saito et al., 1990; Alter, 1995; Idilman et al., 1998; Koike et al., 2000) . Hepatocellular carcinogenesis is a multistep process and thus makes it difficult to understand the precise mechanism of immortalization and transformation at the cellular level. We and others have identified a number of important functional properties of the HCV core protein. These include a trans-regulatory role of several cellular promoters and regulation of cell growth (Lai and Ware, 2000; McLauchlan, 2000; Choi et al., 2001; Ray and Ray, 2001 ). Overproduction and release of nonenveloped HCV nucleocapsids into the bloodstream of an infected host and accumulation of core protein in liver cells of infected chimpanzees in the acute phase of infection have been demonstrated (Maillard et al., 2001) . Accumulation of the core particles may be an unconventional means by which HCV may impose restrictions on its natural host for viral persistence. Hepatic steatosis occurs at a high rate in chronic hepatitis C patients, even in those with cirrhosis, and a close relationship between steatosis and intrahepatic core protein expression has been noted (Fujie et al., 1999) .
We have recently observed that the HCV core protein promotes primary human hepatocytes, a natural host for virus replication and tropism, to an immortalized phenotype (Ray et al., 2000) . Cells that retained an immortalized phenotype displayed a weak level of core protein expression and exhibited continuous growth for more than 3 years. Reactivation of telomerase was observed in HCV core protein mediated immortalized hepatocytes. The present study was designed to examine whether the suppression of core gene expression has an effect upon the maintenance of immortalized hepatocytes and if there are any corresponding consequences on cellular gene expression. Antisense RNA is a major strategy for the downregulation of protein expression and can be approached by the use of a synthetic oligonucleotide or plasmid construct expressing antisense RNA within the cell. The major advantage of using a plasmid construct is the generation of a large quantity of antisense RNA within the cells; also delivery of plasmid DNA is more efficient and specific than the delivery of oligonucleotide (He and Huang, 1997) . Here, we have used an antisense orientation of the core gene cloned under the control of an inducible metallothionein promoter for introduction into HCV core mediated immortalized human hepatocytes. We observed that repression of the core gene expression in the immortalized hepatocytes results in apoptosis and characteristic changes in p53, c-myc, and hTERT expression.
RESULTS

Inhibition of HCV core protein expression induces cell death
Primary human hepatocytes immortalized by the HCV core gene were used in this study. Immortalized hepatocytes expressing an antisense core (AS-core) gene from an inducible metallothionein promoter by treatment with a predetermined dose of ZnCl 2 (100 M) displayed a decrease in cell viability after 6 days and massive cell death between 7 and 10 days (Fig. 1) . In contrast, empty vector transfected hepatocytes, treated similarly with ZnCl 2 , exhibited a growth pattern like that observed with untransfected cells treated with the same predetermined dose of ZnCl 2 . We also used constitutive expression of the antisense core gene, cloned under the control of MuLV LTR promoter in pBabe-puro vector, to study the growth properties of immortalized hepatocytes when core protein expression has been suppressed. Primary human hepatocytes immortalized by introduction of the core gene cloned under the control of the CMV promoter in the pcDNA3 expression vector (Ray et al., 2000) were transfected with the antisense core gene cloned in pBabe-puro vector. Transfected hepatocytes after 4 days of puromycin selection grew for a very short period of time (3-5 days), after which hepatocytes died. On the other hand, mock transfected hepatocytes steadily grew under parallel culture conditions after puromycin selection. This result is in agreement with our AS-core gene expression under the inducible promoter and consistent observations were noted from at least four different experiments. A nonneoplastic human hepatocyte cell line (THLE5B) generated by transfection of primary human liver epithelial cells with SV40 T antigen (Pfeifer et al., 1993) was also used as a negative control. Transfection of the AS-core gene into THLE5B did not display any detectable change in growth characteristics. Introduction of antisense orientation of an unrelated protein (MIP2A) as an additional negative control also did not alter immortalized hepatocyte growth. Results from these different expression systems suggested that antisense core gene expression alters the survival of the HCV core induced immortalized hepatocytes.
Inhibition of HCV core protein expression by antisense core gene
Immortalized human hepatocytes transfected with the AS-core gene cloned under the control of a metallothionein promoter or empty vector were induced with ZnCl 2 (100 M). Cells were harvested after induction for Western blot analysis to determine the level of core protein inhibition. Western blot analysis suggested a weak level of core protein expression in empty vector transfected immortalized hepatocytes, which decreased ϳ60% in AS-core gene transfected hepatocytes on day 2 and remained at a similar level on day 4 and day 6 ( Fig.  2A) , as determined by densitometric scanning. FACS analysis suggested an ϳ72% reduction in median fluorescence intensity upon AS-core gene expression in hepatocytes following induction with ZnCl 2 as compared to uninduced hepatocyte controls (Fig. 2B) . Together, our results suggest that antisense core gene expression decreases core protein to a significant level in immortalized human hepatocytes.
Introduction of antisense core gene results in apoptotic cell death
To determine whether the observed hepatocyte death was associated with apoptosis, both mock and AS-core gene transfected hepatocyte cultures were induced by ZnCl 2 . Cells were harvested between 6 and 7 days and examined for a characteristic DNA ladder for apoptosis. DNA from AS-core gene expressing hepatocytes displayed apoptotic signature oligonucleosome fragments by agarose gel electrophoresis (Fig. 3A) . On the other hand, cells transfected with an empty vector control DNA did not display the characteristic DNA ladder. The level of apoptosis in hepatocytes was also quantified by Cell Death Detection ELISA (Roche), which is based on the quantitative sandwich-immunoassay principle using mouse monoclonal antibodies against DNA and histone. Analysis of the AS-core transfected hepatocytes suggested a significant level of apoptotic cell death as compared to the hepatocytes transfected with vector control (Fig. 3B) . Together, these results indicated that the introduction of the AS-core gene induces apoptosis in hepatocytes immortalized by HCV core protein. Antisense core gene alters cellular gene expression Primary culture of human cells must overcome the first barrier to cellular proliferation, referred to as senescence, which minimally involves the p53 and Rb tumorsuppressor pathways (Stewart and Weinberg, 2000) . p21 can be transcriptionally regulated by the p53 tumor suppressor protein and is thus believed to participate in the execution of p53 effects. Induction of p21 can also be mediated via p53-independent pathways. We have previously reported from in vitro transient transfection studies that core protein transcriptionally regulates a number of cellular promoters, including p53 and p21 (Ray et al., 1997 (Ray et al., , 1998a . Results from our mutational analysis suggested that the core protein responsive element in the p21 promoter is located downstream of the p53-binding site. These data suggested an independent effect of the core protein on p53 and p21 promoters. Here, we examined whether core protein alters the endogenous expression of p53 and p21 genes following induction of the AS-core gene expression by ZnCl 2 in immortalized hu- 
FIG. 3. (A)
Analysis of DNA fragmentation in empty vector and antisense core gene expressing hepatocytes. DNA extracted from the hepatocytes was analyzed by 1.6% agarose gel electrophoresis. The X174-HaeIII digest was used as a marker. (B) Quantitation of apoptotic cell death in vector control and AS-core-expressing immortalized hepatocytes. DNA fragmentation was measured by quantitation of cytosolic oligonucleosome-bound DNA using ELISA (Roche).
FIG. 4. (A)
The mRNA expression levels of p53 and p21 in empty vector and AS-core gene expressing human hepatocytes by RNase protection assay. The protected fragments were analyzed by urea-PAGE, followed by autoradiography. The housekeeping gene L32 was used as a control. (B) Relative abundance of p53 and p21 mRNAs was estimated by densitometric scanning of the autoradiogram after normalization against L-32 and is shown as a bar diagram. gested an ϳ3 times higher level of p53 expression in AS-core expressing cells, as compared to vector transfected control cells (Fig. 5A ), supporting the RNase protection assay result. On the other hand, a slightly lower level of p21 protein expression was observed in AS-core expressing cells as compared to vector transfected control cells. We also examined the Rb protein expression level, and our results did not suggest a detectable alteration when compared to vector transfected control cells. p53 induces apoptotic cell death involving mitochondria, eventually activating procaspase-9 (Marchenko et al., 2000) . Since we observed an increased p53 expression and apoptotic cell death following expression of the AS-core gene, we determined the status of initiator procaspase-9, a downstream target of p53 (Iordanov et al., 2000) by Western blot analysis. Procaspase-9 is cleaved to its active polypeptides of 35 and 10 kDa upon activation. The antibody used in Western blot analysis recognizes the ϳ48-kDa band of procaspase-9. A significant decrease of procaspase-9 was observed in AS-core expressing hepatocytes, as compared to vector control cells (Fig. 5B) . The blot was reprobed with an antibody to actin and exhibited the presence of a similar amount of protein load in each lane. Thus, inhibition of HCV core protein expression appears to activate procaspase-9 of the apoptotic pathway.
Telomerase activity is decreased by antisense core gene expression
Telomerase is a ribonucleoprotein that synthesizes telomeric DNA repeats onto the ends of chromosomes.
The telomerase reaction is considered to be a critical step in allowing cells to escape from senescence and proliferate. Either oncogene activation or a loss of tumor suppressor function is the probable mechanism by which activation of the telomerase reverse transcriptase occurs. We previously observed that telomerase is reactivated in core protein-immortalized human hepatocytes immediately after senescence (Ray et al., 2000) . Here, we examined whether telomerase activity is altered in hepatocytes after expression of the antisense core gene by TRAP assay. Human cervical carcinoma (HeLa) cells and human foreskin fibroblasts (HFF) were used as positive and negative controls, respectively. The telomere length (ladder formation) was elongated in the vector transfected control cells as compared to the AS-core expressing cells (Fig. 6A) . These results suggested that cells expressing the antisense orientation of the core gene exhibited a reduction in telomerase activity. The shortened telomere formed over the course of cell division may be initiating DNA damage through p53-dependent checkpoints, which are reflected by the difference in growth properties of control and experimental hepatocytes.
Since AS-core gene expression reduces telomerase activity, we examined whether the core protein has a role in transcription modulation of hTERT promoter activity. An in vitro transient reporter assay using HepG2 and 293 cells was performed. Cells were cotransfected with a luciferase reporter construct having ϳ800 bp of sequence upstream from the translation start site of the hTERT gene (hTERT-Luc), HCV core, and/or AS-core us- Inhibition of core protein expression induces activation of procaspase-9. Cell lysates were prepared after induction with ZnCl 2 and analyzed for procaspase-9 by Western blot using a specific antibody. The blot was reprobed with an antibody to actin for normalization.
ing lipofectamine. Analysis of luciferase activity in the cell lysates suggested that HCV core protein upregulates hTERT promoter activity in the HepG2 cells (Fig. 6B) . On the other hand, cotransfection of cells with both the core and AS-core gene decreased hTERT promoter activity at the basal level. However, the AS-core gene did not have a detectable effect on hTERT promoter activity. Upregulation of hTERT promoter activity by core protein was also observed in 293 cells at a much higher magnitude (approximately eightfold), as compared to HepG2 cells (figure not shown), and may be responsible for a difference in transfection efficiency. These results suggest that core protein upregulates hTERT activity, which in turn may play a role in the immortalization of normal human hepatocytes.
We observed previously that HCV core protein upregulates c-myc promoter activity (Ray et al., 1995) . c-myc is known to enhance hTERT gene activity at the transcriptional level (Wu et al., 1999; Wang et al., 2000) . To examine whether introduction of the antisense core gene influences c-myc protein expression level, Western blot analysis was performed using cell lysates and a c-mycspecific antibody. Our results suggested that expression of AS-core reduces c-myc protein approximately threefold, when compared to vector transfected control cells (Fig. 6C) .
DISCUSSION
Primary human hepatocytes have a short life span in culture. Introduction of the HCV core gene immortalizes primary human hepatocytes at a frequency of 1.0-1.5 ϫ 10
Ϫ4 . An associated increase in telomerase elongation in these immortalized cells was observed from our earlier study (Ray et al., 2000) . Here, we investigated whether the presence of core protein is necessary for the maintenance of the immortalized human hepatocytes. Expression of an antisense orientation of the core gene into immortalized hepatocytes led to the onset of cell death. Interestingly, a time lag from the onset of antisense core gene expression and cell death was observed. However, the reason for this time lag is unknown. A similar lag period in cell death was observed following expression of the antisense E7 gene in HeLa cells containing human papilloma virus type 18 DNA (Steele et al., 1992) .
The factors that affect the efficacy of the antisense molecule are largely unknown. Earlier studies using the antisense method also suggested a reduction, rather than a complete shutdown, of the target protein (He and Huang, 1997; Wakita et al., 1999; Nakamura et al., 2000) . The effect of antisense RNA depends on the host chromosomal site of transfected DNA integration, level of expression, and its stability within the cell. Most importantly, the concentration of the antisense RNA within the cells needs to be sufficiently high to lead to the hybridization of the antisense RNA to its target. Analysis of core protein expression in immortalized hepatocytes following antisense core gene expression suggested 60-72% reduction in core protein expression within day 2 and remained at a similar level up to our study period of day 6. We observed previously that immortalized hepatocytes express a weak level of core protein (Ray et al., 2000) as compared to other mammalian cells expressing core protein from transient transfection or infection with a recombinant vaccinia virus. Results were very consistent irrespective of whether monoclonal or polyclonal antibodies were used for detection of core protein expression by Western blot or immunofluorescence study. We estimate that the core protein expression level was at least 25 times higher from a recombinant vaccinia virus as compared to hepatocytes immortalized by introduction of the core gene when normalized with actin (unpublished data). Thus, our data with the immortalized hepatocytes suggest that even though these cells express a low level of core protein, its inhibition to ϳ60% determines the threshold for apoptotic cell death. Hepatocarcinogenesis involves alterations in the concerted action of proto-oncogenes, growth factors, and tumor suppressor genes. A variety of viral proteins immortalize cells, suggesting that multiple mechanisms may lead to an escape from senescence. We previously have reported that HCV core protein regulates p53, p21, and c-myc promoter activities based on the in vitro reporter assays (Ray et al., 1997 (Ray et al., , 1998a . Here, we asked whether HCV core protein expression in immortalized human hepatocytes may indeed be associated with modulation of these cellular genes. The p53 expression level in immortalized hepatocytes was elevated upon expression of the antisense core gene. HCV core protein constitutively activates AP-1, which correlates with the activation of JNK and MAPKK, known to regulate AP-1 (Shrivastava et al., 1998) . Premature senescence involving p53 is activated in response to constitutive MEK/MAPK mitogenic signaling (Lin et al., 1998) . Thus, upregulation of p53 expression and activation of procaspase-9 may contribute to cell death in AS-core gene transfected hepatocytes. Therefore, our results suggest that a weak level of core protein expression is detectable in immortalized hepatocytes which is sufficient for maintenance of cell growth and below which cells fail to survive.
A fundamental aspect of p53 is to participate in cellcycle checkpoint and apoptosis functions that regulate homeostatic tissue renewal. This has been suggested from a number of experimental observations. Exogenous p53 expression can suppress the transformed phenotype of many cell types by inducing growth arrest and apoptosis (Soddu and Sacchi, 1998) . p53-deficient mice have a highly penetrant tumor phenotype, with over 90% tumor incidence within 9 months (Moll and Schramm, 1998) . The modulation of p53 by viral proteins has been observed and implicated in cell growth regulation. The highly transformed properties of adenovirus E4 or E6 in addition to E1A and E1B (Nevels et al., 1999a; Steegenga et al., 1999) in cells correlate with a dramatic reduction of p53 steady-state levels, which inversely correlates with E4 or E6 expression (Nevels et al., 1999b) . HTLV-1 Tax protein has been shown to repress transcription of the p53 gene, thus providing a possible mechanism by which this viral protein contributes to transformation (Uittenbogaard et al., 1995) . SV40 large T antigen transforms cells by sequestration and inactivation of p53 and retinoblastoma gene products. Thus, the absence of functional p53 is expected to promote T-antigen mediated tumorigenesis (Herzig et al., 1999) , and a constant availability of T-antigen is necessary for maintenance of immortalized human fibroblasts (Radna et al., 1989) . The E6 and E7 gene products of HPV-16 and -18 can transform human keratinocytes to an immortal or malignant phenotype. While the antisense RNA of E6 reduces cell growth and lowers the ability to form colonies in soft agar, the inhibition of E7 by antisense RNA causes cell death after a lag period (Steele et al., 1992) . HPV-16 E6 stimulates p53 protein degradation in mouse cells and induces lymphomagenesis in a manner indistinguishable from p53 deficiency (Li et al., 1998) . The loss of p53 function at an early stage of urothelial carcinogenesis may result in acquisition of a malignant phenotype by regulating cell cycle related genes (Okamoto et al., 1998) . Results from our study suggest a possible role of HCV core protein mediated regulation of p53 gene expression, which may contribute to immortalization and growth of primary human hepatocytes. Our results also suggest that a threshold level of core protein might be necessary for immortalization and maintenance of the immortalized hepatocytes at an early stage, and ϳ60% inhibition of core protein expression in these immortalized hepato-cytes induces apoptotic cell death (Figs. 1, 2, and 3) . However, we cannot ascertain a threshold value for core protein expression level in the absence of a standard quantitative assay.
More than 85% of human cancers express telomerase activity and a large proportion of human hepatocellular carcinomas are telomerase positive (Tahara et al., 1995) . As the maintenance of telomeres is required for cells to escape from replicative senescence and proliferate indefinitely, immortalization of human cells requires the reactivation of the telomere lengthening enzyme, telomerase (Greider and Blackburn, 1985) . HPV-16 E6 contributes to the immortalization of keratinocytes by mediating the upregulation of hTERT and concomitant activation of telomerase (Veldman et al., 2001) . Our results suggested that core protein upregulates hTERT promoter activity (Ray et al., 2000) . The decrease in telomere length upon antisense core gene expression in immortalized hepatocytes also supports our results from hTERT promoter activity. We also observed a reduction of c-myc expression after introduction of the antisense core gene. Since c-myc plays an important role in cell growth regulation (Dang, 1999) , it is likely that the lower level of c-myc expression may contribute to the cell death process. The mechanism of immortalization by HCV core protein might result from a regulatory role in p53, hTERT, and possibly c-myc overexpression leading to an alteration in hepatocyte turnover. Signal transduction pathways are complex and interdependent. Thus, it is difficult to conclude the exact mechanism of cell death. However, our study highlights the modulation of these important cell growth regulatory genes. Although the level of this modulation is approximately twofold, these changes appear to have physiological relevance in cell growth regulation. At this time, the mechanism of core protein mediated cellular gene regulation is not known. However, available information suggests that core protein does not bind directly with cellular promoters and probably acts through unidentified cellular factors (Ray and Ray, 2001 ). Thus, although HCV core protein expression in primary human hepatocytes altered endogenous cell growth regulatory gene expression, these changes can be reversed by appropriate manipulation, such as introduction of the antisense core gene. HCV core protein has been observed to have a multifunctional activity similar to that seen in a number of other viral proteins with oncogenic potential. Moreover, the immortalization process of primary human epithelial cells itself occurs through a multistep process, and much of these steps are not fully understood. Interestingly, antisense core gene expression in late passage of the immortalized hepatocytes (passage 50) did not exhibit cell death as observed after early immortalization (passage 10) of cells (Basu and Ray, unpublished observations). We have observed that HCV core protein exhibits the ability to modulate a number of important cell cycle regulatory genes, and these effects are altered following antisense core gene expression after immortalization. Cross-talk among cellular genes occurs during the process of immortalization. However, to our knowledge, this is the first report suggesting that HCV core protein may not only be associated with the immortalization of human hepatocytes, but is also required for the maintenance of this phenotypic change.
The effect of core protein from in vitro studies may reflect an aggravated change in primary hepatocytes, suggesting its transformation potential. Thus, in infected liver, HCV core protein may stimulate cells to escape from replicative senescence, giving rise to clonal proliferation. For this, hepatocytes will need to overcome different cell cycle control mechanisms. Further work examining the mechanisms leading to deregulated expression of p53 or c-myc in chronically HCV infected humans may provide understanding of the regulatory pathways which, when defective, contribute to oncogenesis. Furthermore, targeted inhibition of core protein function may offer new therapeutic modalities in HCV mediated pathogenesis.
MATERIALS AND METHODS
Cells and plasmids
Primary human hepatocytes immortalized by transfection with the HCV core genomic region from genotype 1a under the control of a CMV early promoter in pcDNA3 expression vector or under the control of MuLV LTR in the pBabe-puro expression vector were generated as described previously (Ray et al., 2000) . Hepatocytes were seeded on a collagen type I coated plate and maintained at 37°C in a defined culture medium supplemented with growth factors and antimicrobials (SAGM, Clonetics, Walkersville, MD). The antisense orientation of the HCV core gene (encoding amino acids 1-191) from the same genotype 1a was cloned under the control of an inducible metallothionein promoter in MTCB6ϩ vector (kindly provided by Frank J. Rauscher, III, Wistar Institute, Philadelphia) or under the control of a MuLV LTR into pBabepuro vector.
Transfection and maintenance of hepatocytes HCV core mediated immortalized hepatocytes (from passage 10) were transfected with the antisense orientation of the core gene (AS-core) or an empty vector using lipofectamine. Briefly, cells were transfected with an inducible promoter linked with antisense orientation to HCV core gene or empty vector DNA (mock control). After 48 h of transfection, cells were treated with G418 (800 g/ml), and resistant cells were selected and induced with a predetermined dose of ZnCl 2 (100 M) for antisense core gene expression. There was no detectable growth inhibitory property of the immortalized hepa-tocytes at 100 M ZnCl 2 . Alternatively, cells transfected with the antisense core gene cloned into pBabe-puro vector were treated with puromycin (2 g/ml) for 4 days and resistant colonies were pooled.
HCV core protein expression
The expression of HCV core protein in hepatocytes was examined by Western blot analysis and flow cytometry. Western blot analysis was performed (Ray et al., 2000) using a rabbit antibody to HCV core protein (kindly provided by Arvind Patel, University of Glasgow, England). An anti-rabbit immunoglobulin coupled with horseradish was used as the second antibody to detect core protein by chemiluminescence (ECL, Amersham). Flow cytometric analysis was conducted using a specific monoclonal antibody, O-17A, known to recognize epitopes between amino acid residues 80 and 160 (Virogen, Watertown, MA) and an anti-mouse Ig conjugated to fluorescein isothiocyanate (FITC) as a second antibody. Hepatocytes (ϳ10 5 ) were fixed by treatment with 10% formaldehyde. Fixed cells were incubated with 2% normal AB human serum (Sigma) in PBS for 15 min. Cells were incubated with the monoclonal antibody O-17A in PBS containing 4% FCS and 0.01% sodium azide, followed by treatment with the second antibody conjugated to FITC. After being washed, FITC stained cells were analyzed by FACScan (Becton Dickinson) with Cell Quest Version 3.2 software. Ten thousand cells were analyzed for each sample and a gate was set on the basis of dot plot for 90°light scatter versus forward angle light scatter to exclude dead cells and debris from analysis. Nonspecific background staining was determined with mock transfected control cells treated only with the FITC conjugated anti-mouse Ig.
Growth characteristics
Hepatocytes were plated in triplicate at a density of ϳ10 5 /ml and incubated with hepatocyte growth medium containing ZnCl 2 (100 M). Viable cells were counted every 24 h by trypan blue exclusion.
Cellular gene expression
The same batch of cells used in FACS analysis was examined for cellular gene expression to synchronize the level of HCV core protein expression with cellular gene expression. An RNase protection assay was performed using custom-made probes (Pharmingen) to investigate the modulation of cellular genes as previously described (Ray et al., 1989) . Control human RNA provided with the assay kit was used to ensure detection of specific bands. Total cellular RNA was isolated from mock transfected control or AS-core cells. RNA was hybridized with radiolabeled custom-made antisense RNA multiprobes (p53, p21, and L32). The reaction mixture was digested with RNase A and RNase T1. The protected fragments were analyzed by urea-polyacrylamide gel (5%) electrophoresis, followed by autoradiography. The autoradiogram was densitometrically scanned to compare mRNA levels between control and experimental cells after the values were normalized with respect to the housekeeping gene, L32. Western blot analysis was performed to analyze the expression levels of p53, p21, Rb, and procaspase-9 proteins in control and experimental cells using specific antibodies (Santa Cruz Biotechnologies, Santa Cruz, CA). The level of c-myc protein was also measured by Western blot analysis using a specific monoclonal antibody (kindly provided by Linda Penn, University of Toronto, Toronto, Ontario, Canada). Briefly, equal amounts of proteins from whole-cell lysates in sample buffer were separated by SDS-PAGE. Proteins were transferred onto nitrocellulose, incubated with specific antibodies, and detected by chemiluminescence (Amersham). Cellular actin was detected similarly in the reprobed blot and used as an internal control for relative quantitation of the proteins of interest in mock control and AS-core transfected cells by densitometric scanning.
Analysis for apoptotic cell death
Apoptotic cell death was analyzed from DNA fragmentation by agarose gel electrophoresis as previously described (Ray et al., 1996 (Ray et al., , 1998b . Additionally, the apoptotic response in hepatocytes was quantified from the cytosolic oligonucleosome-bound DNA by a cell death detection ELISA (Roche Diagnostics).
Telomerase and transient reporter gene assay
Telomerase activity was detected in cells early after expression of the AS-core gene (between 5 and 6 days) by a PCR-based telomerase-repeat amplification protocol as described previously (Ray et al., 2000) . An in vitro transient reporter assay was performed using an ϳ800-bp regulatory region of hTERT linked with a luciferase reporter gene (kindly provided by Riccardo DallaFavera, Columbia University, New York) and effector plasmid DNAs. HepG2 or 293 cells were cotransfected with the reporter gene construct, HCV core gene , and/or AS-core in pBabe-puro. Empty vector DNA was used as a control for mock transfection. The total amount of DNA was kept constant in the transfection mixture by the addition of empty vector. Cells were harvested in the reporter lysis buffer (Promega, Madison, WI) 48 h after transfection, and luciferase activity was determined by a luminometer (Optocomp II, MGM Instruments) as described previously (Ray et al., 1998a) . The luciferase activity was normalized with respect to protein concentration in the cell lysates.
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